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O B J E C T I V E S This study compared the ability of coronary artery calcium (CAC) and thoracic aortic
calcium (TAC) to predict coronary heart disease (CHD) and cardiovascular disease (CVD) events.
B A C KG ROUND Coronary artery calcium has been shown to strongly predict CHD and CVD events,
but it is unknown whether TAC, also measured within a single cardiac computed tomography (CT) scan,
is of further value in predicting events.
METHOD S A total of 2,303 asymptomatic adults (mean age 55.7 years, 38% female) with CT scans
were followed up for 4.4 years for CHD (myocardial infarction, cardiac death, or late revascularizations)
and CVD (CHD plus stroke). Cox regression, adjusted for Framingham risk score (FRS), examined the
relation of Agatston CAC and TAC categories, and log-transformed CAC and TAC with the incidence of
CHD and CVD events and receiver-operator characteristic (ROC) curves tested whether TAC improved
prediction of events over CAC and FRS.
R E S U L T S A total of 53% of subjects had Agatston CAC scores of 0; 8% 1 to 9; 19% 10 to 99; 12%
100 to 399; and 8% 400. For TAC, proportions were 69%, 5%, 12%, 8%, and 7%, respectively; 41
subjects (1.8%) experienced CHD and 47 (2.0%) CVD events. The FRS-adjusted hazard ratios (HR) across
increasing CAC groups (relative to10) ranged from 3.7 (p 0.04) to 19.6 (p 0.001) for CHD and from
2.8 (p  0.07) to 13.1 (p  0.001) for CVD events; only TAC scores of 100 to 399 predicted CHD and CVD
(HR: 3.0, p  0.008, and HR: 2.3, p  0.04, respectively); these risks were attenuated after accounting for
CAC. Findings were consistent when using log-transformed CAC and TAC Agatston and volume scores.
The ROC curve analyses showed CAC predicted CHD and CVD events over FRS alone (p 0.01); however,
TAC did not further add to predicting events over FRS or CAC.
CONC L U S I O N S This study found that CAC, but not TAC, is strongly related to CHD and CVD
events. Moreover, TAC does not further improve event prediction over CAC. (J Am Coll Cardiol Img
2009;2:319–26) © 2009 by the American College of Cardiology Foundation
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320oronary artery calcium (CAC), a marker of
subclinical atherosclerosis assessed by
computed tomography (CT), is strongly
associated with the risk of future coronary
eart disease (CHD) events and mortality (1–7).
AC provides incremental value over global risk
ssessment (e.g., Framingham risk scores [FRS])
nd has been recommended for enhancing cardio-
ascular risk stratification in intermediate-risk per-
ons (8–10).
Segments of the thoracic aorta can be assessed by
he noncontrast CT scan used to assess CAC,
ithout any additional scanning or radiation. Aortic
alcium is an established marker of atherosclerosis
11–13). As with CAC, the prevalence of thoracic
ortic calcium (TAC) increases with age, is associ-
ted with coronary risk factors (14), and correlates
losely with CAC (15), but whether TAC predicts
HD and cardiovascular disease (CVD) events has
not been previously shown. We aim to
examine in a cohort of asymptomatic per-
sons whether TAC predicts CVD events
over FRS, and more importantly, over the
well-established strength of CAC.
M E T H O D S
A total of 2,303 asymptomatic adults
(mean age 55.7  9.6 years, 38% female)
without a history of CVD who had base-
line CT scans assessed both for CAC and
TAC were followed up for myocardial
infarction, cardiac death, coronary revas-
cularizations, and stroke over a mean
follow-up of 4.4 (0.7) years, ranging from 0.8 to
7.8 years. Subjects were either physician- or self-
referred clinical patients who agreed to be part of
the cardiac research database (n  1,304, 57%) or
enrollees in the EISNER (Early Identification of
Subclinical Atherosclerosis by Noninvasive Imaging
Research) study, which included CAC scanning
(n  999, 43%). Persons with known atrial fibril-
lation were not included. We could not obtain the
follow-up status in 180 subjects, who are not
included in the above sample. Except for being
younger (mean age 51 years), these subjects were
roughly comparable to those subjects included in
the study with respect to other risk factors. The
current study was approved by the Cedars-Sinai Med-
ical Center Institutional Review Board (Institutional
Review Board numbers 3351, 3354, and 3974).
Subjects were scanned using either an electron
m
se
y
e
ebeam CT (C-150XP Scanner or E-speed, GeneralElectric/Imatron, South San Francisco, California) or
multidetector scanner (4-slice Somatom Volume
Zoom, Siemens, Berlin and Munich, Germany). Li-
censed radiologic technicians acquired a single scan on
each patient consisting of approximately 30 to 40
slices encompassing the heart from the carina to the
apex, with a 30- to 35-cm field of view sufficient to
include the entire heart as well as the ascending and
descending thoracic arteries. For the electron beam
CT scanners, we used 3-mm slices, 100-ms exposure,
130-kV tube voltage, 63 mAs (88 mAs for E-speed),
and prospective electrocardiographic triggering at 60%
of the RR interval; for the multidetector scanner, we
used 250-ms exposures, 2.5-mm slices, 120-kV volt-
age, 42 mAs, and prospective triggering at 400 ms
before the next R wave (16). Breath-holding instruc-
tions were also given to minimize misregistration.
Foci of CAC were identified and scored by an
experienced technician, using semiautomatic software
(ScImage, Inc., Los Altos, California), and verified by
an imaging cardiologist. Lesion-specific scores were
calculated as the product of the area of each calcified
focus and peak CT number (scored as 1 if 130 to 199
HU, 2 if 200 to 299 HU, 3 if 300 to 399 HU, and 4
if 400 HU or greater) and summed across all lesions
identified within left main, left anterior descending,
left circumflex, and right coronary arteries to provide
arterial specific calcium scores and across arteries to
provide a total Agatston calcium score (17). TAC
included calcium scored from segments of the ascend-
ing and descending portion of the thoracic aorta
visible in the coronary CT scan from the lower edge of
the pulmonary artery bifurcation to the apex of the
subject’s heart. Calcification in the aortic arch was not
included in the TAC score we report. Readers differ-
entiated aortic and mitral valvular calcium from aortic
wall calcium. Calcification in the aortic root (e.g.,
above the aortic valve) is included in ascending TAC.
An example of ascending and descending TAC as
well as CAC in the left anterior descending and right
coronary arteries is shown in Figure 1.
A fasting lipid profile plus glucose (Cholestech,
Hayward, California), 2 readings of blood pressure
(readings averaged), brief medical history, and
weight and height for calculation of body mass
index were obtained. Diabetes was defined by self-
reported history, taking medication, or having a
fasting glucose of 7.0 mmol/l (126 mg/dl) or
casual glucose of 11.1 mmol/l (200 mg/dl). The
10-year risk of CHD was estimated by the FRS
(18). Those with diabetes were assigned a risk score
of 20% (or higher if determined by the FRSA B B R E V I A T I O N S
A N D A C R O N YM S
CAC coronary artery calciu
CHD coronary heart disea
CI confidence interval
CT computed tomograph
CVD cardiovascular diseas
FRS Framingham risk scor
HR hazard ratio
ROC receiver-operator
characteristiccalculation).
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321Follow-up for CHD and CVD events consisted
of administering patient questionnaires and inter-
views and/or using hospital records. Myocardial
infarctions, strokes, and deaths were verified by 2
physicians from an independent review of admis-
sion reports, discharge summaries, and consulta-
tion/laboratory reports. Revascularizations were
verified by hospital records. All deaths were verified
by National Death Index and/or independent re-
view of death reports by 2 physicians. Hard CHD
events included myocardial infarction or cardiac
death, total CHD events included hard CHD plus
late revascularizations (90 days), and total CVD
included total CHD plus stroke.
S T A T I S T I C A L M E T H O D S
We compared age, sex, and risk factor distributions
according to CAC and TAC Agatston score cate-
gory (0, 1 to 9, 10 to 99, 100 to 399, and 400
indicating none/minimal, mild, moderate, and sig-
nificant calcification, respectively, based on guide-
lines for CAC [19]) and the distribution of CAC
Figure 1. Example of Scan Showing Calciﬁcation in the AAO
and DAO, and LAD and RCA
Example of scan showing calciﬁcations (arrows) in the ascend-
ing thoracic aorta (AAO) and descending thoracic aorta (DAO),
the aortic valve (AV), left anterior descending artery (LAD), and
right coronary artery (RCA). Note that the AV calciﬁcation was
not included in the aortic scoring.ith TAC (overall and by age group) using thechi-square test of proportions or analysis of vari-
ance. The bivariate relation of CAC and TAC
categories with CHD and CVD was examined
similarly. Cox proportional hazards regression ex-
amined the FRS-adjusted hazard ratios (HRs) for
events associated with CAC and TAC calcium
categories of 10 to 99, 100 to 399, and 400,
relative to those with scores 0 to 9 (which formed
our reference group, because the CAC  0 group
had an insufficient number of events to serve as a
suitable reference group), defining follow-up time
as the time between the baseline scan date and the
first occurrence of an event. Receiver-operator char-
acteristic (ROC) curves and c-statistics were also
obtained from the Cox models, and equality of areas
(20) was compared for models examining: 1) FRS
alone; 2) FRS plus CAC categories; 3) FRS plus
TAC categories; and 4) FRS plus CAC and TAC
categories together. To examine comparability of
results with continuously measured CAC and
TAC, we also conducted similar analyses using log
transformations of CAC and TAC. For total CHD
and CVD events, only late revascularizations were
included, and 5 early revascularizations (90 days)
were censored. Time to the earliest occurrence of
the specified event in each analysis was used for the
Cox regression analyses. All analyses were per-
formed using Stata version 8 (StataCorp LP, Col-
lege Station, Texas).
R E S U L T S
Persons with higher levels of CAC or TAC were
significantly older, had higher body mass index, and
were more likely to be diabetic, to have higher
systolic blood pressure, to have higher FRS, and to
have more CHD and CVD events. Although those
with higher CAC scores were less likely to be
women and had lower high-density lipoprotein
cholesterol levels, those with higher TAC scores
were more commonly women and current smokers
(Table 1).
Overall 53% of subjects had CAC scores of 0, 8%
of 1 to 9, 19% of 10 to 99, 12% of 100 to 399, and
8% of 400. For TAC, these proportions were
69%, 5%, 12%, 8%, and 7%, respectively. The TAC
scores were closely associated (p  0.0001) with
CAC scores (Fig. 2). Of 47% (n  1,088) of
subjects with any CAC, slightly over half (51%, n
554) did not have TAC, and of 31% (n  724) of
subjects with any TAC, 26% (n  190) did not
have CAC. Overall, 45% (n  1,025) of subjects
had both CAC and TAC absent (scores of 0 for
Table 1. Descriptive Statistics and Event Frequencies for Hard CHD, Total CHD, and Total CVD by CAC and TAC Categories
Overall
(n  2,303)
CAC TAC
0
(n  1,215)
1 to 9
(n  182)
10 to 99
(n  438)
100 to 399
(n  278)
400
(n  190)
Trend
p Value
0
(n  1,579)
1 to 9
(n  114)
10 to 99
(n  277)
100 to 399
(n  182)
400
(n  151)
Trend
p Value
Age (yrs) 56 10 52 9 56 8 58 9 61 8 64 8 0.0001 53 8 57 8 60 8 64 7 68 6 0.0001
Women, n (%) 885 (38) 581 (48) 60 (33) 140 (32) 68 (24) 36 (19) 0.0001 576 (36) 55 (48) 113 (41) 77 (42) 64 (42) 0.02
Total cholesterol
(mg/dl)
213 41 212 39 220 41 214 42 209 43 209 43 0.12 212 40 217 45 213 40 211 39 213 45 0.72
HDL-C (mg/dl) 55 17 56 17 54 16 54 18 52 15 53 16 0.0001 55 17 55 19 55 15 55 16 57 17 0.09
Body mass index
(kg/m2)
27 5 26 5 26 4 27 5 27 5 27 5 0.0001 26 5 27 5 27 5 27 4 27 6 0.006
Diabetes, n (%) 157 (7) 55 (5) 9 (5) 46 (11) 17 (6) 30 (16) 0.0001 92 (6) 8 (7) 19 (7) 24 (13) 14 (9) 0.001
SBP (mm Hg) 129 18 125 17 131 18 131 18 133 18 138 20 0.0001 126 17 132 17 132 17 135 18 141 21 0.0001
Current smoking,
n (%)
150 (7) 69 (6) 14(8) 30 (7) 22 (8) 15 (8) 0.10 92 (6) 8 (7) 22 (8) 14 (8) 14 (9) 0.04
Family history,
n (%)
661 (29) 353 (29) 41 (23) 123 (28) 87 (31) 57 (30) 0.62 460 (29) 35 (31) 79 (29) 51 (28) 36 (24) 0.26
FRS (% 10-yr
CHD risk)
7 7 5 6 8 6 9 7 10 7 13 7 0.0001 6 6 7 7 9 7 11 7 11 8 0.0001
Hard CHD
events, n (%)
16 (0.7) 1 (0.1) 1 (0.6) 2 (0.5) 6 (2.2) 6 (3.2) 0.0001 5 (0.3) 1 (0.9) 5 (1.8) 3 (1.7) 2 (1.3) 0.003
Total CHD
events, n (%)
41 (1.8) 2 (0.2) 2 (1.1) 6 (1.4) 13 (4.7) 18 (9.5) 0.0001 16 (1.0) 2 (1.8) 8 (2.9) 9 (5.0) 6 (4.0) 0.0001
Total CVD
events, n (%)
47 (2.0) 3 (0.3) 3 (1.7) 7 (1.6) 15 (5.4) 19 (10.0) 0.0001 20 (1.3) 3 (2.6) 8 (2.9) 9 (5.0) 7 (4.6) 0.0001
CAC  coronary artery calcium; CHD  coronary heart disease; CVD  cardiovascular disease; FRS  Framingham Risk Score; HDL-C  high-density lipoprotein cholesterol; SBP  systolic blood pressure; TAC  thoracic aortic calcium.
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323both) and 23% (n  534) of subjects were positive
or both CAC and TAC (scores 0 for each) and
8% (n  424) had at least mild CAC and TAC
scores10 for each). Across increasing age groups,
here was a closer relation of presence of CAC and
AC together; in those age 40 years, 15% had
ither and 2% had both; these figures increased to 28%
nd 5% for ages 40 to 49 years and 35% and 17% for
ges 50 to 59 years, and both CAC and TAC together
ere more common than one alone by ages 60 to 69
ears: 38% and 41%, and especially in those ages70
ears: 21% and 72%, respectively.
Sixteen participants (0.7%) had hard CHD
vents (13 myocardial infarctions and 3 cardiac
100%
80%
60%
40%
20%
0%
CAC=0
n=1215 (53%) n=438 (19%n=182 (8%)
CAC 1-9 CAC10-99
84
70
60
8
11
16
6
1
3
8
4
5
6
12
8
Figure 2. Distribution of TAC According to Category of CAC
Values indicate the percentage of participants in each thoracic aort
400) with indicated coronary artery calcium (CAC) scores (0, 1 to
of TAC groups across CAC groups.
Table 2. Framingham Risk Score–Adjusted Hazard Ratios for Ha
Regression Analyses Including CAC or TAC Categories
Hard CHD Events
CAC
10 (n  1,397) 1.0
10 to 99 (n  438) 2.4 (0.3–17.3)
100 to 399 (n  278) 10.5 (2.1–53.9)†
400 (n  190) 12.0 (2.2–64.5)†
TAC
10 (n  1,693) 1.0
10 to 99 (n  277) 3.8 (1.1–12.6)*
100 to 399 (n  182) 2.9 (0.7–12.1)
400 (n  151) 2.1 (0.4–10.8)
*p  0.05; †p  0.01; ‡p  0.001.
Abbreviations as in Table 1.eaths), 41 (1.8%) with total CHD events (above
6 hard CHD events plus 19 late angioplasties and
late bypass surgeries), and 47 (2.0%) with any
total) CVD event (CHD plus 6 strokes). Increas-
ng CAC and TAC categories were significantly
ssociated with the incidence of hard CHD events
nd total CHD and CVD events (p trend 0.0001
or all, except p  0.003 for TAC for hard CHD
vents) (Table 1).
Relative to those with CAC scores10, those with
AC scores of 100 to 399 and CAC scores of 400
ad significantly increased risks for future hard CHD
vents (HR: 10.5 and 12.0, respectively). Total CHD
vents were significantly more likely for those with
n=278 (12%) n=190 (8%)
AC 100-399
n=151 (7%)
TAC 100-399
n=182 (8%)
TAC 10-99
TAC 1-9
n=114 (5%)
TAC=0
n=1579 (69%)
n=277 (12%)
41
26
27
15
16
21
6
24
17
5
lcium (TAC) score category (0, 1 to 9, 10 to 99, 100 to 399, and
to 99, 100 to 399, and 400). p  0.001 comparing distribution
HD, Total CHD, and Total CVD Events From Individual Cox
Total CHD Events Total CVD Events
1.0 1.0
3.7 (1.03–13.3)* 2.8 (0.9–8.3)
11.9 (3.8–37.0)‡ 8.8 (3.4–23.1)‡
19.6 (6.3–60.8)‡ 13.1 (5.0–34.2)‡
1.0 1.0
2.0 (0.9–4.6) 1.5 (0.7–3.5)
3.0 (1.3–6.9)† 2.3 (1.04–5.0)*
2.1 (0.8–5.6) 1.9 (0.8–4.6))
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324CAC 10 to 99, CAC 100 to 399, and CAC 400
HR: 3.7, 11.9, and 19.6, respectively). Total CVD
vents were significantly more likely for those with
AC 10 to 99, CAC 100 to 399, and CAC 400
HR: 3.4, 8.8, and 13.1, respectively). For TAC,
ompared with those with TAC10, increased HRs
FRS-adjusted) were observed for TAC 10 to 99
HR: 3.8) in predicting hard CHD, and TAC 100 to
99 for total CHD events (HR: 3.0) and total CVD
vents (HR: 2.3) (Table 2). In separate Cox models
ontaining both CAC and TAC categories to-
ether (results not shown), although HRs for CAC
1-Specificity
1.000.750.500.25
FRS (0.757)
FRS+TAC (0.767) FRS+CAC+TAC (0.840)
FRS+CAC (0.834)
00
ROC Curve Analysis for CAC and TAC in Predicting Hard
ts
r the receiver-operator characteristic (ROC) curve is provided in
s. The p values for contrasts: addition of CAC over FRS alone,
further addition of TAC, p  0.67; addition of TAC over FRS alone,
CHD  coronary heart disease; FRS  Framingham Risk Score;
eviations as in Figure 2.
1-Specificity
1.000.750.500.25
FRS (0.748)
FRS+TAC (0.769) FRS+CAC+TAC (0.858)
FRS+CAC (0.857)
00
ROC Curve Analysis for CAC and TAC in Predicting Total
ts
r the ROC curve is provided in parentheses. The p values for con-
ition of CAC over FRS alone, p  0.004; further addition of TAC,
addition of TAC over FRS alone, p  0.28. Abbreviations as inp
nd 3.emained essentially unchanged, HRs associated with
ach TAC category were attenuated and no longer
ignificant.
Figures 3 to 5 show results of the ROC analyses
or FRS alone, FRS plus CAC or TAC, and FRS
lus CAC and TAC. The addition of CAC pro-
ided incremental value for predicting events over
RS alone (p  0.004 for total CHD and p 
.006 for total CVD events); however, there was no
dditional value of TAC for predicting events over
RS (p  0.70, p  0.28, and p  0.43 for hard
HD, total CHD, and total CVD events, respec-
ively). Importantly, the addition of TAC to a
odel consisting of FRS plus CAC also provided
o incremental predictive value for hard CHD or
otal CHD or CVD events (p  0.67, p  0.92,
nd p  0.99, respectively).
In models in which CAC and TAC were defined
ontinuously, LogCAC significantly predicted both
ard CHD (HR: 1.5, 95% CI: 1.2 to 1.9), total
HD (HR: 1.7, 95% CI: 1.4 to 2.0), and total
VD (HR: 1.6, 95% CI: 1.3 to 1.8) events. Al-
hough log TAC was not significantly related to the
isk of hard CHD (HR: 1.2, 95% CI: 0.99 to 1.4),
here was a weak relation with total CHD (HR:
.2, 95% CI: 1.04 to 1.3) and total CVD (HR: 1.1,
5% CI: 1.02 to 1.3). However, in models with
oth LogCAC and LogTAC, only LogCAC re-
ained significantly associated with events (hard
HD HR: 1.5, total CHD HR: 1.7, total CVD
R: 1.6, all p  0.002), whereas LogTAC did not
p  0.54 for all). From ROC curve analyses, over
nd above FRS, LogCAC (p  0.08, 0.002, and
.004 for hard CHD, total CHD, and total CVD,
espectively) but not LogTAC (p  0.23 for all end
oints) significantly improved discrimination. Ad-
itionally, LogTAC did not add incremental value
o FRS  LogCAC (p  0.82 for all end points).
When we examined our primary results accord-
ng to CAC and TAC volume (log-transformed)
or our end points of hard CHD, total CHD, and
otal CVD events, these results were entirely con-
istent with our Agatston score–based analyses and
howed that CAC but not TAC remain strong
redictors (independent of FRS) of hard CHD,
otal CHD, and total CVD (p  0.01 to p  0.001
or CAC and p  0.20 for TAC). Moreover, in
OC analyses, CAC provided incremental value
ver FRS for the prediction of events (p  0.07 for
ard CHD, p  0.02 for total CHD, and p  0.01
or CVD events), but TAC did not add further to1.00
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Figure 3.
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325D I S C U S S I O N
This is the first report examining the role of TAC
as a predictor of CHD and CVD events. Although
there is a modest relation of TAC to future CHD
and CVD events, TAC does not improve predic-
tion of events over global risk assessment. We
confirm the established incremental value of CAC
in predicting cardiovascular events over and above
risk factors or Framingham risk scores as shown
previously (3,5,6); others also have shown that
CAC independently predicts mortality (4,7). How-
ever, no previous investigation has examined the
ability of TAC (which can be evaluated in the same
scan as CAC without additional scanning or radi-
ation exposure) to predict future cardiovascular
events or whether it adds further to prediction over
CAC in a large screened cohort.
Aortic calcium in either the ascending or de-
scending thoracic aorta has been shown to be
related closely to CAC, suggesting a common
underlying systemic vascular atherosclerotic process
(21,22). We have previously shown TAC to be
associated with several risk factors, including age,
low-density lipoprotein cholesterol, body mass in-
dex, systolic blood pressure, and cigarette smoking
(14). Others have shown age, cigarette smoking,
and coronary calcium to best predict calcification of
the entire descending aorta down to the iliac arter-
ies (23). Also, aortic calcification is significantly
more common in those with (63%) versus without
(22%) (p  0.05) multivessel angiographic disease
(24) and has a sensitivity of 56% and specificity of
72% for obstructive CAD (25). Finally, abdominal
aortic calcium from radiographic images has been
shown to predict vascular morbidity and mortality
in the Framingham Heart Study (26). Associations
of aortic calcium quantitated by CT, including
TAC with clinical events, however, have not been
previously examined.
Our study has several potential limitations. Im-
portantly, our measure of aortic calcium comprises
only that found in the segments of the ascending
and descending thoracic aorta visible from the
coronary calcium scan; therefore, our results are not
applicable to the remainder of the descending aorta,
e.g., abdominal aorta, where significant calcium
occurs (27). Relationships with overall abdominal
aortic calcium and events may be different than
what we report for TAC. Also, we had a limited
number of end points, particularly hard CHD,
which may limit the validity of our findings (e.g.,
possible model overfitting). However, the consis- gtency of our findings using CAC and TAC as
continuous log-transformed predictors, suggests the
robustness of our results. We did not have a
sufficient number of peripheral arterial disease end
points to examine whether TAC was more impor-
tant than CAC for predicting such events. More-
over, we did not have the power to compare
prediction in older and younger groups or by gender
separately. Also, because the Agatston score cut
points used were developed to classify severity of
CAC, one could question whether they can be
similarly used to quantitate extent of TAC. How-
ever, our analyses using continuous log-transformed
scores and volume scores provided consistent re-
sults. Finally, as we studied self-referred volunteers
mainly of Caucasian ethnicity, our results may not
be generalizable to other groups; however, our
patient population is thus similar to other screened
cohorts (1,3,4), with the exception of population-
based studies such as the MESA (Multiethnic
Study of Atherosclerosis) (5).
C O N C L U S I O N S
CAC screening provides independent and incre-
mental utility in predicting the risk of CVD over
global risk assessment, but evaluation of TAC does
not further refine clinical event prediction.
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